"By combining our scientific expertise with the KDA's deep understanding of patient needs, we are confident in our ability to develop a transformative therapy for KD." "KDA is excited to partner with ...

Attruby (acoramidis), a near complete TTR stabilizer, has been approved by FDA to reduce cardiovascular death and ...

The American Society for Radiation Oncology (ASTRO) issued today an updated clinical guideline for physicians who use ...